Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
DelMar Pharmaceuticals has announced the appointments of three additional neuro-oncologists to its Scientific Advisory Board (SAB).
read more
Catalent has completed the $1.2 billion acquisition of Paragon Bioservices, a viral vector development and manufacturing partner for gene therapies.
read more
CalAmp has announced a collaboration with Cryoport to develop a next generation condition monitoring system to further assure the security of global temperature controlled pharmaceutical shipments.
read more
PCI Pharma Services has announced the following management updates.
read more
Synpromics announce a partnership for the commercialization of a number of inducible promoters to improve the manufacturing of biopharmaceuticals.
read more
DILIsym Services announced the FDA has renewed its multi-seat license for the company’s flagship quantitative systems toxicology modeling software, DILIsym®.
read more
Charles River Laboratories has invested in Resero Analytics™, a software company focused on providing solutions to the biopharmaceutical industry to harness its data.
read more
AGC Biologics has announced the appointment of Christopher Holt as Site Head/General Manager of its Bothell, Washington operations.
read more
PharmScript announced the acquisition of Rx Med, a long-term care pharmacy located near Nashville, Tennessee.
read more
IDLogiq® innovations have been selected by the FDA for the Pilot Project Program under the DSCSA to prototype and develop a system that can address the national security of the drug supply chain.
read more
Dr. Reddy’s Laboratories announced the launch of Daptomycin for Injection, 500mg/vial single-dose vial, a therapeutic equivalent generic version of Cubicin® for Injection.
read more
CURE Pharmaceutical has closed on the previously announced acquisition of Chemistry Holdings, a formulation technology company that is develops delivery systems for a variety of industries.
read more
Elligo Health Research has announced the launch of its innovative IntElligo Research Stack™ clinical technology.
read more
Cumberland Pharmaceuticals has entered into an exclusive agreement with China's Winhealth Pharma Group for the licensing rights of Acetadote®.
read more
The FDA has posted warning letters to five companies who produce products labeled as homeopathic for significant violations of CGMP regulations.
read more